Top-News
Pharmazeutika USA

Galectin Therapeutics News

Aktie
WKN:  A1JV3R ISIN:  US3632252025 US-Symbol:  GALT
3,06 €
+0,22 €
+7,75%
06.05.24 11:11:45
Handeln Depot/Watchlist
Aktienanzahl *
59,43 Mio.
Marktkapitalisierung *
172,95 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 13.01.2023

Galectin Therapeutics News

12.10.22 - PR Newswire
Thinking about buying stock in Autolus Therapeutics, Uber, Galectin Therapeutics, El Pollo LoCo, or BioNano Genomics?
Thinking about buying stock in Autolus Therapeutics, Uber, Galectin Therapeutics, El Pollo LoCo, or BioNano Genomics? PR Newswire
14.04.22 - PR Newswire
Thinking about buying stock in Galectin Therapeutics, Dolphin Entertainment, Rite Aid, Protalix Biotherapeutics, or Aterian?
Thinking about buying stock in Galectin Therapeutics, Dolphin Entertainment, Rite Aid, Protalix Biotherapeutics, or Aterian? PR Newswire
14.07.21 - PR Newswire
Thinking about buying stock in Powerbridge Technologies, Galectin Therapeutics, Clene, Velodyne Lidar, or CleanSpark?
Thinking about buying stock in Powerbridge Technologies, Galectin Therapeutics, Clene, Velodyne Lidar, or CleanSpark? PR Newswire
09.07.21 - PR Newswire
Thinking about buying stock in Galectin Therapeutics, Hall of Fame Resort & Entertainment, PubMatic, 360 DigiTech, or Aslan Pharmaceuticals?
Thinking about buying stock in Galectin Therapeutics, Hall of Fame Resort & Entertainment, PubMatic, 360 DigiTech, or Aslan Pharmaceuticals? PR Newswire
19.04.21 - PR Newswire
Thinking about buying stock in Westport Fuel Systems, Galectin Therapeutics, eMagin Corp, Aemetis, or BioLineRx?
Thinking about buying stock in Westport Fuel Systems, Galectin Therapeutics, eMagin Corp, Aemetis, or BioLineRx? PR Newswire
14.04.21 - PR Newswire
Thinking about buying stock in Galectin Therapeutics, Moleculin Biotech, Microvision, Nikola Corp, or Ardelyx?
Thinking about buying stock in Galectin Therapeutics, Moleculin Biotech, Microvision, Nikola Corp, or Ardelyx? PR Newswire
18.12.17 - PR Newswire
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Galectin Therapeutics Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Galectin Therapeutics Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
30.01.17 - PR Newswire
Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present February 2nd
Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present February 2nd PR Newswire
30.01.17 - PR Newswire
Galectin Therapeutics to Webcast, Live, at VirtualInvestorConferences.com on February 2
Galectin Therapeutics to Webcast, Live, at VirtualInvestorConferences.com on February 2 PR Newswire
28.08.14 - PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of ...
12.08.14 - PR Newswire
Law Offices of Marc S. Henzel Announces Securities Class Action Periods
Law Offices of Marc S. Henzel Announces Securities Class Action Periods PR Newswire
08.08.14 - PR Newswire
Lifshitz & Miller Law Firm Announces Investigation of Cobalt International Energy, Inc., DreamWorks Animation SKG, Inc., Galectin Therapeutics, Inc., Impax Laboratories, Inc., Peoples Federal Banc
Lifshitz & Miller Law Firm Announces Investigation of Cobalt International Energy, Inc., DreamWorks Animation SKG, Inc., Galectin Therapeutics, Inc., Impax Laboratories, Inc., ...
06.08.14 - PR Newswire
Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Galectin Therapeutics Inc.
Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Galectin Therapeutics Inc. PR Newswire
01.08.14 - PR Newswire
Attention Galectin Therapeutics Inc. Investors: Galectin Misled Investors According to a Recently Filed Class Action
Attention Galectin Therapeutics Inc. Investors: Galectin Misled Investors According to a Recently Filed Class Action PR Newswire
31.07.14 - PR Newswire
Harwood Feffer LLP Announces Investigation of Galectin Therapeutics Inc.
Harwood Feffer LLP Announces Investigation of Galectin Therapeutics Inc. PR Newswire
30.07.14 - PR Newswire
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Galectin Therapeutics, Inc.
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Galectin Therapeutics, Inc. PR Newswire
29.07.14 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics, Inc. - GALT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics, Inc. - GALT PR Newswire
24.07.13 - PR Newswire
Galectin Therapeutics Announces First Patient Dosed in Phase 1 Trial of GR-MD-02, a Potential First-in-Class Treatment for Fatty Liver Disease with Advanced Fibrosis
Galectin Therapeutics Announces First Patient Dosed in Phase 1 Trial of GR-MD-02, a Potential First-​in-Class Treatment for Fatty Liver Disease with Advanced Fibrosis PR Newswire
01.07.13 - PR Newswire
Galectin Therapeutics Submits Fast Track Application to FDA for GR-MD-02 in Treatment of Fatty Liver Disease with Advanced Fibrosis
Galectin Therapeutics Submits Fast Track Application to FDA for GR-MD-02 in Treatment of Fatty Liver Disease with Advanced Fibrosis PR Newswire
21.06.13 - PR Newswire
Galectin Therapeutics Names Industry-Veteran Jack W. Callicutt Chief Financial Officer
Galectin Therapeutics Names Industry-​Veteran Jack W. Callicutt Chief Financial Officer PR Newswire

Newssuche

Videos

17.05.24 +7,67%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »